Faculty profile
Edward Putnins
Back to facultyResearch
Read how they describe their research on their University of British Columbia profile.
Latest papers
Fabrication and evaluation of a novel patient-specific 3D-printed simulation model for oral surgical training.
BMC medical education · 2025
Enamel matrix proteins bind to wound matrix proteins and regulate their cell-adhesive properties.
European journal of oral sciences · 2007
Latest funding
- $100,000
Novel MAO-B inhibitors' regulation of dual-specificity phosphatase expression and their effects on periodontal disease pathogenesis
CIHR · 2025 · Nominated PI
- $100,000
Regulation of Periodontal Disease Pathogenesis by the Effects of Novel Monoamine Oxidase B Inhibitors
CIHR · 2022 · Nominated PI
- $100,000
Regulation of Periodontal Disease Pathogenesis by the Effects of Novel Monoamine Oxidase B Inhibitors
CIHR · 2021 · Nominated PI
2 publications.
Fabrication and evaluation of a novel patient-specific 3D-printed simulation model for oral surgical training.
Gholami L, Putnins E, von Bergmann H, Bagheri A, Tarzemany R
Enamel matrix proteins bind to wound matrix proteins and regulate their cell-adhesive properties.
Narani N, Owen GR, Häkkinen L, Putnins E, Larjava H
Novel MAO-B inhibitors' regulation of dual-specificity phosphatase expression and their effects on periodontal disease pathogenesis
Principal investigators: Putnins, Edward E
Keywords: Animal Disease Models; Bone Resorption; Cell Culture Models; Chronic Inflammation; Drug Development; Dual-Specificity Phosphatases (Dusps); Il-1 Family; Monoamine Oxidase Inhibitors; Osteoclastogenesis; Periodontal Diseases
Regulation of Periodontal Disease Pathogenesis by the Effects of Novel Monoamine Oxidase B Inhibitors
Principal investigators: Putnins, Edward E
Keywords: Animal Disease Models; Bone Resorption; Cell Culture Models; Chronic Inflammation; Drug Development; Inflammasome; Monoamine Oxidase Inhibitors; Osteoclastogenesis; Periodontal Diseases; Tnf-Alpha
Regulation of Periodontal Disease Pathogenesis by the Effects of Novel Monoamine Oxidase B Inhibitors
Principal investigators: Putnins, Edward E
Keywords: Animal Disease Models; Bone Resorption; Cell Culture Models; Chronic Inflammation; Dopamine; Drug Development; Inflammasome; Monoamine Oxidase Inhibitors; Periodontal Diseases
Development of Novel Polar MAO B Inhibitors for the Treatment of Epithelial Barrier Diseases
Principal investigators: Putnins, Edward E
Keywords: Blood-Brain Barrier; Epithelial Barrier Integrity; Gastrointestinal Tract Infections; Inflammation; Irritable Bowel Syndromes; Monoamine Oxidase; Monoamine Oxidase B Inhibitors; Periodontal Disease; Polar Mao B Inhibitors; Tight Junctions
Protection and Regulation of Oral and Gastrointestinal Mucosal Epithelial Barriers by MAO B Inhibitors and Their Novel Polar Derivatives
Principal investigators: Putnins, Edward E
Keywords: Amphiregulin Shedding; Animal Models; Barrier; Cell Culture; Drug Redevelopment; Elisa; Gastrointestinal Disease; Inflammation; Monoamine Oxidase And Their Inhibitors; Periodontal Disease Pathogenesis; Tight Junctions
Protection and Regulation of Oral and Gastrointestinal Mucosal Epithelial Barriers by MAO B Inhibitors and Their Novel Polar Derivatives
Principal investigators: Putnins, Edward E
Keywords: Amphiregulin Shedding; Animal Models; Barrier; Cell Culture; Drug Redevelopment; Elisa; Gastrointestinal Disease; Inflammation; Monoamine Oxidase And Their Inhibitors; Periodontal Disease Pathogenesis; Tight Junctions
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Oral Biological & Medical Sciences
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on July 30, 2025 from the university directory, publication records and CIHR, NSERC and SSHRC funding.